Zhujiang Hospital clinical trial pipeline

6 trials changed in the last 30 days: 0 stopped, 5 with notable changes, 1 with a minor change only.

1. Notable

   Neoadjuvant Toripalimab in Combination With Gemcitabine and…Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects

   Primary completion pushed from Oct 3, 2026 to Oct 3, 2027

   Also in this update: Completion pushed from Apr 3, 2027 to Apr 3, 2028

   Zhujiang Hospital·Phase 2· NCT04861584· Registry history of NCT04861584 on ClinicalTrials.gov (opens the registry)

   Updated Oct 9, 2026

2. Notable

   RC48 Combined With Toripalimab as Neoadjuvant Therapy for…RC48 Combined With Toripalimab as Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients

   Primary completion pushed from May 1, 2026 to May 1, 2028

   Also in this update: Completion pushed from May 1, 2027 to May 1, 2029

   Zhujiang Hospital·Phase 1/2· NCT06341400· Registry history of NCT06341400 on ClinicalTrials.gov (opens the registry)

   Updated Oct 8, 2026

3. Notable

   Detaenial Sigmoid Neobladder and Ileal Neobladder

   Primary completion pushed from Aug 30, 2025 to Aug 30, 2027

   Also in this update: Trial status changed: Unknown → Recruiting; Completion pushed from Sep 30, 2025 to Sep 30, 2028

   Zhujiang Hospital·Not applicable· NCT03108196· Registry history of NCT03108196 on ClinicalTrials.gov (opens the registry)

   Updated Oct 9, 2026

4. Notable

   Capsule Sparing Cystectomy and Radical Cystoprostatectomy · Bladder…Capsule Sparing Cystectomy and Radical Cystoprostatectomy · Bladder Cancer

   Primary completion pushed from Dec 1, 2025 to Dec 1, 2028

   Also in this update: Completion pushed from Dec 1, 2026 to Jul 1, 2029

   Zhujiang Hospital·Not applicable· NCT05067101· Registry history of NCT05067101 on ClinicalTrials.gov (opens the registry)

   Updated Oct 9, 2026

5. Notable

   Supraspinal Control of Lower Urinary Tract Function · Orthotopic…Supraspinal Control of Lower Urinary Tract Function · Orthotopic Sigmoid Neobladder

   Primary completion pushed from Jan 1, 2025 to Dec 1, 2028

   Also in this update: Trial status changed: Unknown → Recruiting; Completion pushed from Jun 1, 2025 to Jun 1, 2029; and 1 more change in the last 30 days

   Zhujiang Hospital·Not specified· NCT05558111· Registry history of NCT05558111 on ClinicalTrials.gov (opens the registry)

   Updated Oct 8, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.